HISAMITSU PHARMACEUTICAL CO.,INC. Environmental Analytics
Environmental and financial analysis dashboard for HISAMITSU PHARMACEUTICAL CO.,INC.. Industry: MANUFACTURING
Company Overview for HISAMITSU PHARMACEUTICAL CO.,INC.
Highlights
Showing data for FY2022
Operational Environmental Cost
$4.94m
Operational Environmental Cost Intensity
0.52%
Total Environmental Cost
$27m
Total Environmental Cost Intensity
2.86%
ΔOperational Environmental Cost (2020-2022)
$0.65m
Decoupling Rate (2020-2022)
-15%
Adjusted EBITDA
$131m
Adjusted EBITDA Margin
14%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 6.88% | 23.53% | N/A | ||
| 0.12% | 0.14% | 0.19% | N/A | |
| 9.86% | -2.08% | N/A | ||
| 0.28% | 0.31% | 0.34% | N/A | |
| $4m | $5m | $5m | N/A | |
| 8.94% | 5.70% | N/A | ||
| 0.40% | 0.45% | 0.52% | N/A | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| 13.28% | 14.20% | N/A | ||
| 1.58% | 1.84% | 2.33% | N/A | |
| 12.41% | 12.54% | N/A | ||
| 1.98% | 2.29% | 2.86% | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
14%
Adjusted EBIT Margin
10%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$1,075m | $1,044m | $942m | $947m | |
| -2.91% | -9.72% | 0.50% | ||
N/A | $895m | $807m | $791m | |
| 0.00% | 85.78% | 85.61% | 83.57% | |
N/A | $148m | $136m | $156m | |
| 0.00% | 14.22% | 14.39% | 16.43% | |
N/A | $111m | $102m | $119m | |
| 0.00% | 10.66% | 10.80% | 12.57% | |
| ENVIRONMENTAL COST DATA | ||||
$4m | $5m | $5m | N/A | |
| 0.40% | 0.45% | 0.52% | 0.00% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
N/A | $144m | $131m | N/A | |
| 0.00% | 13.77% | 13.87% | 0.00% | |
N/A | $107m | $97m | N/A | |
| 0.00% | 10.21% | 10.27% | 0.00% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
MANUFACTURE OF PHARMACEUTICAL PREPARATIONS
Scope 1 (% of Sales)
0.19%
Scope 2 (% of Sales)
0.34%
Operational Environmental Cost Intensity
0.52%
Scope 3 (% of Sales)
2.33%
Total Environmental Cost Intensity
2.86%
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
HISAMITSU PHARMACEUTICAL CO.,INC. | JP | $5m | 0.52% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022